GL1X · GenesisL1 explorer

MolNFT v1 · #113839 · protein

SMYD2 in complex with small molecule inhibitor compound-2

5ARF · N-lysine methyltransferase SMYD2: “SMYD2 in complex with small molecule inhibitor compound-2”. X-ray diffraction, 3 ligands (I9H, SAM, ZN), 4 pockets (best druggability 0.80). MolNFT v1 #113839 on GenesisL1: 3D structure, binding…

PDB
5ARF
Type
protein
Length
425 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
N-lysine methyltransferase SMYD2
EC
2.1.1.-, 2.1.1.43
UniProt
Q9NRG4
Ligands
I9H, SAM, ZN
Pockets
4 · best druggability 0.80

Structure

x-ray diffraction · 1 distinct chain · 51% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AN-lysine methyltransferase SMYD2 (EC 2.1.1.-, 2.1.1.43)protein42551% helix, 14% strandQ9NRG4

Ligands and binding sites

  • I9H · N-[3-(4-chlorophenyl)-1-{N'-cyano-N-[3-(difluoromethoxy)phenyl]carbamimidoyl}-4,5-dihydro-1H- pyrazol-4-yl]-N-ethyl-2-hydroxyacetamide · ligand · chains A
  • SAM · S-adenosylmethionine · ligand · chains A
  • ZN · Zinc ion · metal · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19420.800.82100I9H, SAM
21070.400.7622empty
3850.380.7715empty
4530.250.7214empty

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 5ARF · SMYD2 in complex with small molecule inhibitor compound-2 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9NRG4 · AlphaFold monomer V2.0 prediction for N-lysine methyltransferase SMYD2 (Q9NRG4) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.